Clinical Trial Update: Clinical Efficacy of Potassium Canrenoate in Sinus Rhythm Restoration Among Patients With Atrial Fibrillation. [Phase 4]

View source ↗

Summary

This Phase 4 trial assesses the clinical efficacy of potassium canrenoate in restoring sinus rhythm in patients with paroxysmal atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Potassium Canrenoate (potassium canrenoate)

Snippet

Sponsor: National Institute of Cardiology, Warsaw, Poland | Conditions: Atrial Fibrillation, Paroxysmal | Phase 4 | Status: UNKNOWN